Table 1.
Year | Study design | Study population | Type of sample | Microbiological techniques | Pathogens investigated | Prevalence (%) | Influenza vaccination (%) | Reference |
---|---|---|---|---|---|---|---|---|
1991–1992 | Cross-sectional study (Saudi Arabia) | Pilgrims suffering URTIa and LRTIb and seeking care in four hospitals/medical centers (n = 761) | Throat swabs, sputum | Cell culture/cytopathic effect and staining using virus-specific monoclonal antibodies | Influenza A | 4.5 | [14] | |
Influenza B | 2.0 | |||||||
Influenza overall | 6.5 | |||||||
Parainfluenza 1 | 2.0 | |||||||
Parainfluenza 2 | 1.7 | |||||||
Parainfluenza 3 | 2.2 | |||||||
Parainfluenza overall | 5.9 | |||||||
Adenovirus | 4.7 | |||||||
Respiratory syncytial virus | 2.4 | |||||||
Mixed viral infections | ND | |||||||
No virus | 80.6 | |||||||
1994 | Cross-sectional study (Saudi Arabia) | Pilgrims suffering pneumoniac and seeking care in two hospitals (n = 64) | Serum, sputum broncho-alveolar lavage and naso-pharyngeal aspirate | Direct immunofluorescence staining | Influenza A | 3.1 | [15] | |
Influenza B | 1.6 | |||||||
Influenza overall | 4.7 | |||||||
Parainfluenza 1 | 0 | |||||||
Parainfluenza 2 | 1.6 | |||||||
Parainfluenza 3 | 0 | |||||||
Adenovirus | 0 | |||||||
Respiratory syncytial virus | 0 | |||||||
Mixed viral infections | 0 | |||||||
No virus | 89.1% | |||||||
2000 | Cross sectional study (Saudi Arabia) | Pilgrims suffering ILId and presenting at outpatient clinics (n = 305) | Serum | ELISA | Influenza A | 5.9 | 4.3 | [16] |
Influenza B | 11.5 | |||||||
Influenza overall | 14.8 | |||||||
Mixed viral infections | ND | |||||||
No virus | 82.0% | |||||||
2003 | Cross-sectional study (Saudi Arabia) | Pilgrims suffering URTIe and seeking care in three hospitals (n = 500) | Throat swabs | Cell culture/cytopathic effect and staining using virus-specific monoclonal antibodies | Influenza A | 0.6 | 4.4% | [17] |
Influenza B | 5.4 | |||||||
Influenza overall | 6.0 | |||||||
Parainfluenza 1,2,3 | 0.8 | |||||||
Adenovirus | 0 | |||||||
Respiratory syncytial virus | 1.4 | |||||||
Enterovirus | 0 | |||||||
Mixed viral infections | ND | |||||||
No virus | 89.2% | |||||||
2004 | Cross-sectional study (Saudi Arabia) | Pilgrims suffering ILIf and seeking care in hospitals/medical centers (n = 360) | Throat swab | Not described | Influenza overall | 12.8 | 2.2% | [18] |
(including 70.9% influenza B Sichuan, 1.8% influenza B Hong Kong, 14.6% influenza A untyped, 7.3% influenza A-H1N1, 5.5% influenza A-H3N2 calculated from a mixed sample of 46 positive pilgrims and 9 positives non-pilgrims) | ||||||||
Mixed viral infections | ND | |||||||
No virus | 84.7% | |||||||
2004–2005 | Cross-sectional study (Saudi Arabia) | Iranian pilgrims suffering respiratory symptomsg and presenting at to medical centers (n = 105) | Gargled pharyngeal secretions, and serum | Cell culture/cytopathic effect and staining using virus-specific monoclonal antibodies - ELISA | Influenza A (pharynx) | 1.9 | [19] | |
Influenza B (pharynx) | 11.4 | |||||||
Influenza overall | 13.3 | |||||||
Parainfluenza (pharynx) | 0 | |||||||
Adenovirus (pharynx) | 36.2 | |||||||
Respiratory syncytial virus (pharynx) | 1.9 | |||||||
Influenza A-H1N1 (serology) | 6.9 | |||||||
Influenza A-H3N2 (serology) | 6.1 | |||||||
Influenza B-Hong Kong (serology) | 8.5 | |||||||
Influenza B-Sichuan (serology) | 12.3 | |||||||
Influenza overall (serology) | 21.5 | |||||||
Mixed viral infections | ND | |||||||
No virus (pharynx) | 48.6% | |||||||
No virus (serology) | 58.1% | |||||||
2005 | Cross-sectional study (Saudi Arabia) | Pilgrimsh suffering respiratory symptomsi attending the British Hajj Delegation clinic in Mecca, or at Mina encampment (n = 202) | Nasal swabs | Rapid diagnostic test (QuickVue) - PCR | Influenza rapid test | 4.5 | 27.7 | [20] |
Influenza A-H1N1 | 0.5 | |||||||
Influenza A-H3N2 | 9.9 | |||||||
Influenza B | 3.5 | |||||||
Influenza overall | 13.9 | |||||||
Respiratory syncytial virus | 4.5 | |||||||
Mixed viral infections | ND | |||||||
No virus | 86.1 | |||||||
2005 | Cross-sectional study (Saudi Arabia) | International pilgrims suffering respiratory symptomsf recruited at two hospitals and at two airports (n = 483) | Throat swab | Not described | Influenza overall | 9.7 | 29.9 | [21] |
(including 17.0% influenza B Sichuan, 6.4% influenza B Hong Kong, 29.8% influenza A untyped, 34.0% influenza A-H1N1, 12.8% influenza A-H3N2) | ||||||||
Mixed viral infections | ND | |||||||
No virus | 90.3 | |||||||
2005–2006 | Cross-sectional study (Saudi Arabia and UK) | UK pilgrims suffering respiratory symptomsj during their stay in Saudi Arabia or upon returning to the UK (n = 555) | Nasal swabs | Rapid diagnostic test (QuickVue) - PCR | Influenza (Rapid test) | 3.2 | [22] | |
Influenza-A (PCR) | 8.2 | |||||||
Influenza B (PCR) | 2.3 | |||||||
Influenza overall (PCR) | 10.5 | |||||||
Mixed viral infections | ND | |||||||
No virus | 90.1% | |||||||
2006 | Cross-sectional study (Saudi Arabia) | British pilgrims suffering respiratory symptomsk attending the British Hajj Delegation clinic in Mecca or at Mina encampment (n = 150) and Saudi pilgrimsk attending the National Guard Health Affair clinic at Mina (n = 110) | Nasal swabs | Rapid diagnostic test (QuickVue) - PCR | Influenza rapid test | 3.5 | 23.1 | [23] |
Influenza A | 8.1 | |||||||
Influenza B | 2.3 | |||||||
Influenza overall | 10.4 | |||||||
Parainfluenza 1 | 0 | |||||||
Parainfluenza 2 | 0 | |||||||
Parainfluenza 3 | 0.4 | |||||||
Parainfluenza overall | 0.4 | |||||||
Respiratory syncytial virus | 0.4 | |||||||
Rhinovirus | 9.2 | |||||||
Mixed viral infections | 0.8% | |||||||
No virus | 85.4% | |||||||
2006 | Cross-sectional airport study (Iran) | Iranian Returning pilgrims suffering ARIl (n = 255) | Nasal wash | Cell culture/cytopathic effect and staining using virus-specific monoclonal antibodies - PCR | Influenza A | 5.1 | 85.5% | [24] |
Influenza B | 5.1 | |||||||
Influenza overall | 10.2 | |||||||
Parainfluenza 1 | 5.5 | |||||||
Parainfluenza 2 | 1.6 | |||||||
Parainfluenza 3 | 0.8 | |||||||
Parainfluenza overall | 7.9 | |||||||
Adenovirus | 5.5 | |||||||
Respiratory syncytial virus | 1.6 | |||||||
Rhinovirus | 5.9 | |||||||
Enterovirus | 2.0 | |||||||
Mixed viral infections | 0.4% | |||||||
No virus | 67.5% | |||||||
2009 | Cross sectional airport survey (Iran) | Iranian returning pilgrims suffering respiratory symptomsm (n = 275) | Throat swabs | Cell culture/cytopathic effect - PCR | Influenza A-H1N1 (culture) | 1.1 | 100% | [25] |
Influenza A-H3N2 (culture) | 1.8 | |||||||
Influenza B (culture) | 6.2 | |||||||
Influenza overall (culture) | 9.1 | |||||||
Influenza A-H1N1 (PCR) | 1.8 | |||||||
Influenza A-H3N2 (PCR) | 2.9 | |||||||
Influenza B (PCR) | 7.3 | |||||||
Influenza overall (PCR) | 12.0 | |||||||
Mixed viral infections | ND | |||||||
No virus (culture) | 90.9 | |||||||
No virus (PCR) | 88.0 | |||||||
2010 | Cross-sectional airport study (Saudi Arabia) | Arriving pilgrimsn suffering from URTIo (n = 713) | Throat swabs | Not described | Influenza A-H1N1 | 3.1 | 26.9 | [26] |
Influenza A-H3N2 | 1.7 | |||||||
Influenza B-Hong Kong | 1.1 | |||||||
Influenza B-Sichuan | 2.1 | |||||||
Influenza overall | 8.0 | |||||||
Respiratory syncytial virus | 3.1 | |||||||
Mixed viral infections | ND | |||||||
No virus | 88.9% | |||||||
2011 | Cross-sectional study (Saudi Arabia) | Australian pilgrims suffering from ILIp, at Mina encampment (n = 80) | Nasal swabs | PCR | Influenza A | 6.3 | [27] | |
Influenza B | 3.8 | |||||||
Influenza overall | 10.1 | |||||||
Parainfluenza 1 | 0 | |||||||
Parainfluenza 2 | 0 | |||||||
Parainfluenza 3 | 1.3 | |||||||
Rhinovirus | 48.8 | |||||||
Enterovirus | 2.5 | |||||||
Mixed viral infections | 2.5 | |||||||
No virus | 41.3 | |||||||
2013 | Cross-sectional study (Saudi Arabia) | Pilgrimsq suffering from ILIr, at Mina encampment (n = 112) | Naso-pharyngeal or throat swabs | PCR | Influenza A-H1N1 | 0.9 | 31.3% | [28] |
Influenza A-H3N2 | 3.6 | |||||||
Influenza overall | 4.5 | |||||||
Parainfluenza 1 | 0.9 | |||||||
Parainfluenza 2 | 0 | |||||||
Parainfluenza 3 | 1.8 | |||||||
Parainfluenza overall | 2.7 | |||||||
Rhinovirus | 26.8 | |||||||
Adenovirus | 2.7 | |||||||
Coronavirus OC43 and 229E | 2.7 | |||||||
Mixed viral infections | 2.7 | |||||||
No virus | 62.5 | |||||||
2013 | Cross sectional study (Saudi Arabie) | Pilgrimss admitted to 15 healthcare facilities with bilateral pneumonia (n = 38) | Sputum | PCR | Influenza A | 15.8 | [29] | |
Influenza B | 0 | |||||||
Parainfluenza 1 | 0 | |||||||
Parainfluenza 2 | 0 | |||||||
Parainfluenza 3 | 2.6 | |||||||
Parainfluenza 4 | 0 | |||||||
Parainfluenza overall | 2.6 | |||||||
Adenovirus | 0 | |||||||
Respiratory syncytial virus | 2.6 | |||||||
MERS-Cov | 0 | |||||||
CoV-229E | 7.9 | |||||||
CoV-NL63 | 0 | |||||||
CoV-HKU1 | 0 | |||||||
CoV-OC43 | 5.3 | |||||||
CoV overall | 13.2 | |||||||
Enterovirus | 0 | |||||||
Metapneumovirus | 0 | |||||||
Rhinovirus | 39.5 | |||||||
Bocavirus | 0 | |||||||
Mixed viral infections | 15.8 | |||||||
No virus | 56.7 | |||||||
2014 | National survey (Austria) | Returning Austrian pilgrims seeking caret in hospitals/medical centers (n = 7) | Serum, sputum, throat swab, or bronchoalveolar lavage | PCR | MERS-CoV | 0 | 0 | [30] |
Influenza A-H1N1 | 0 | |||||||
Influenza A-H3N2 | 28.6 | |||||||
Influenza B | 42.9 | |||||||
Influenza overall | 71.4 | |||||||
Rhinovirus | 26.6 | |||||||
Mixed viral infections | 0 | |||||||
No virus | 0 |
Based on history and physical examination.
Evidence of pulmonary consolidation on physical examination and radiograph.
Acute episode associated with respiratory symptoms and radiological evidence of airspace disease of less than 4 weeks' duration.
Fever and at least two of the following: headaches, myalgia, cough, sore throat or coryza.
Sore throat or fever ≥38.3 °C, and cough, headache, runny nose, sneezing, or myalgia.
Fever of at least 38 °C, started within 72 h of presentation; along with history of cough and/or sore throat.
Common cold defined by sore throat, rhinitis, fever, ILI defined by fever >38.5 °C, myalgia, rhinitis and cough, sinubronchitis defined by headaches, purulent postnasal discharge or purulent sputum, cough and fever and pneumonia defined on radiographic findings.
Mainly Indian pilgrims.
Cough, sore throat, rhinorrhea and fever.
Cough, sore throat, rhinorrhea and fever within one week of the onset.
Cough, sore throat, rhinorrhea and fever.
Two of the following conditions: fever, cough, sore throat, congestion, and sinus pain within the past 3 weeks during the Hajj.
Cough, sore throat and fever.
Mainly from Indonesia, Turkey and Pakistan.
Fever and/or headaches and/or myalgia and at least of the following symptoms: runny nose, sneezing, sore throat, cough with or without sputum, difficulty of breathing.
Subjective (or proven) fever plus one respiratory symptom (e.g. dry or productive cough, runny nose, sore throat, shortness of breath) for 3 days or less.
Mainly from Saudi Arabia.
Subjective (or proven) fever and at least one respiratory symptom such as cough, sore throat and rhinorrhea.
Mainly from Asia.
Fever and/or respiratory symptoms.